[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"dissection-aortic\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:dissection-aortic":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,49],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":30,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100555113","post-market-registry-for-gore-tag-thoracic-branch-endoprosthesis-100555113",false,"NCT06507865","Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis","Characterization of Mid-term Post Market Clinical Follow Up of GORE® TAG® Thoracic Branch Endoprosthesis Facilitated Aortic Arch and Descending Aorta Intervention","Inclusion Criteria:\n\nPatient or legally authorized representative (LAR) provides written authorization and\u002For consent per institution and geographical requirements Patient has been or is intended to be treated with an eligible registry device Patient is age ≥ 18 years at time of informed consent signature.\n\nExclusion Criteria:\n\nPatient who is, at the time of consent, unlikely to be available for standard of care (SOC) follow-up visits as defined by the site's guidelines and procedures.\n\nPatient with exclusion criteria required by local law. Patient is currently enrolled in or plans to enroll in any concurrent drug and\u002For device study within 12 months of Together Registry enrollment. Subjects cannot be enrolled in another Together Registry module protocol.","ALL","18 Years",{"count":19,"type":20},200,"ESTIMATED","2 Years","OBSERVATIONAL","The goal of this observational study is to collect mid-term post-market clinical follow-up data of GORE® TAG® Thoracic Branch Endoprosthesis used according to the standard medical practice in patients presenting with vascular disease. This registry aims to answer questions related to the efficacy and safety of GORE® TAG® Thoracic Branch Endoprosthesis.",[25,26,27,28,29],"Aneurysm","Dissection, Aortic","TAA Thoracoabdominal Aortic Aneurysm","Thoracic Aortic Aneurysm","Transection Aorta",[31,25,32,33,34,35],"TEVAR","Dissection","Aorta","Endovascular stent graft","Thoracic branch endoprosthesis","RECRUITING","2025-05-05",{"date":39,"type":40},"2025-05-09","ACTUAL",{"date":42,"type":40},"2025-02-20",{"date":44,"type":20},"2031-04",{"name":46,"class":47},"W.L.Gore & Associates","INDUSTRY",20,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":4,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":16,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":77},"100534191","arch-size-study-for-anatomical-variations-100534191","NCT06235619","Arch Size Study for Anatomical Variations","CT Anatomical Characteristics of the Aortic Arch in Subjects With or Without Aneurysms Requiring Treatment","Inclusion Criteria:\n\nall patients with aortic arch CT scan at investigating centers\n\nExclusion Criteria:\n\nnone","0 Years","100 Years",{"count":59,"type":20},500,"The aortic arch with a common origin of the innominate and left carotid artery (CILCA) prevalence in the general population is 13.6%. Its reputation as a benign anatomical variant has been ultimately shattered by further studies that identified the CILCA arch as a potential marker for thoracic aortic disease (TAD) The aim of this work is to report the CT anatomical characteristics of the aortic arch in subjects with or without aneurysms requiring treatment, in 5 major European cardiovascular centers.",[62,25,26],"Aortic Arch",[64,65,66],"Aortic arch","Bovine arch","Thoracic aortic disease","2025-04-30",{"date":69,"type":40},"2025-05-02",{"date":71,"type":40},"2024-09-01",{"date":73,"type":20},"2026-12-01",{"name":75,"class":76},"IRCCS San Raffaele","OTHER",1]